Filiberti A - Search Results

1

Loss of Osteopontin Expression Reduces HSV-1-Induced Corneal Opacity.

Filiberti A, Gmyrek GB, Montgomery ML, Sallack R, Carr DJJ. Filiberti A, et al. Invest Ophthalmol Vis Sci. 2020 Aug 3;61(10):24. doi: 10.1167/iovs.61.10.24. Invest Ophthalmol Vis Sci. 2020. PMID: 32785676 Free PMC article.

2

Herpes Simplex Virus 1 (HSV-1) 0ΔNLS Live-Attenuated Vaccine Protects against Ocular HSV-1 Infection in the Absence of Neutralizing Antibody in HSV-1 gB T Cell Receptor-Specific Transgenic Mice.

Gmyrek GB, Filiberti A, Montgomery M, Chitrakar A, Royer DJ, Carr DJJ. Gmyrek GB, et al. Among authors: filiberti a. J Virol. 2020 Nov 23;94(24):e01000-20. doi: 10.1128/JVI.01000-20. Print 2020 Nov 23. J Virol. 2020. PMID: 32999018 Free PMC article.

3

Distinguishing Features of High- and Low-Dose Vaccine against Ocular HSV-1 Infection Correlates with Recognition of Specific HSV-1-Encoded Proteins.

Carr DJJ, Gmyrek GB, Filiberti A, Berube AN, Browne WP, Gudgel BM, Sjoelund VH. Carr DJJ, et al. Among authors: filiberti a. Immunohorizons. 2020 Oct 9;4(10):608-626. doi: 10.4049/immunohorizons.2000060. Immunohorizons. 2020. PMID: 33037098 Free PMC article.

4

Lack of neonatal Fc receptor does not diminish the efficacy of the HSV-1 0ΔNLS vaccine against ocular HSV-1 challenge.

Carr DJJ, Berube AN, Filiberti A, Gmyrek GB. Carr DJJ, et al. Among authors: filiberti a. Vaccine. 2021 Apr 28;39(18):2526-2536. doi: 10.1016/j.vaccine.2021.03.075. Epub 2021 Apr 1. Vaccine. 2021. PMID: 33814229 Free PMC article.

5

An intact complement system dampens cornea inflammation during acute primary HSV-1 infection.

Filiberti A, Gmyrek GB, Berube AN, Royer DJ, Carr DJJ. Filiberti A, et al. Sci Rep. 2021 May 13;11(1):10247. doi: 10.1038/s41598-021-89818-9. Sci Rep. 2021. PMID: 33986436 Free PMC article.

6

Osteopontin contributes to virus resistance associated with type I IFN expression, activation of downstream ifn-inducible effector genes, and CCR2⁺CD115⁺CD206⁺ macrophage infiltration following ocular HSV-1 infection of mice.

Filiberti A, Gmyrek GB, Berube AN, Carr DJJ. Filiberti A, et al. Front Immunol. 2023 Jan 4;13:1028341. doi: 10.3389/fimmu.2022.1028341. eCollection 2022. Front Immunol. 2023. PMID: 36685562 Free PMC article.

7

Complement Suppresses the Initial Type 1 Interferon Response to Ocular Herpes Simplex Virus Type 1 Infection in Mice.

Carr DJJ, Filiberti A, Gmyrek GB. Carr DJJ, et al. Among authors: filiberti a. Pathogens. 2024 Jan 13;13(1):74. doi: 10.3390/pathogens13010074. Pathogens. 2024. PMID: 38251381 Free PMC article.

8

Immune Contributions to Osteoarthritis.

Lopes EBP, Filiberti A, Husain SA, Humphrey MB. Lopes EBP, et al. Among authors: filiberti a. Curr Osteoporos Rep. 2017 Dec;15(6):593-600. doi: 10.1007/s11914-017-0411-y. Curr Osteoporos Rep. 2017. PMID: 29098574 Review.

9

Targeting Doublecortin-Like Kinase 1 (DCLK1)-Regulated SARS-CoV-2 Pathogenesis in COVID-19.

Undi RB, Larabee JL, Filiberti A, Ulahannan S, Aravindan S, Stroberg E, Barton LM, Duval EJ, Mukhopadhyay S, Henthorn JC, Akins D, Houchen CW, Huycke MM, Ali N. Undi RB, et al. Among authors: filiberti a. J Virol. 2022 Sep 14;96(17):e0096722. doi: 10.1128/jvi.00967-22. Epub 2022 Aug 9. J Virol. 2022. PMID: 35943255 Free PMC article.

10

Low-Level Vagus Nerve Stimulation Suppresses Post-Operative Atrial Fibrillation and Inflammation: A Randomized Study.

Stavrakis S, Humphrey MB, Scherlag B, Iftikhar O, Parwani P, Abbas M, Filiberti A, Fleming C, Hu Y, Garabelli P, McUnu A, Peyton M, Po SS. Stavrakis S, et al. Among authors: filiberti a. JACC Clin Electrophysiol. 2017 Sep;3(9):929-938. doi: 10.1016/j.jacep.2017.02.019. Epub 2017 May 30. JACC Clin Electrophysiol. 2017. PMID: 29759717 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

52 results

Search Page